dityrosine has been researched along with Kidney Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asano, A; Kimoto, Y; Masuda, A; Nishinohara, M; Ochi, T; Sugiyama, A; Takeuchi, T | 1 |
| Aypar, U; Orhan, H; Sahin, A; Sahin, G; Vermeulen, NP | 1 |
| Kirschbaum, B | 1 |
1 trial(s) available for dityrosine and Kidney Diseases
| Article | Year |
|---|---|
Urinary lipid and protein oxidation products upon halothane, isoflurane, or sevoflurane anesthesia in humans: potential biomarkers for a subclinical nephrotoxicity.
Topics: Acetone; Aldehydes; Anesthetics, Inhalation; Biomarkers; Female; Glycosuria; Halothane; Humans; Isoflurane; Kidney; Kidney Diseases; Lipids; Male; Methyl Ethers; Oxidation-Reduction; Proteinuria; Sevoflurane; Tyrosine | 2013 |
2 other study(ies) available for dityrosine and Kidney Diseases
| Article | Year |
|---|---|
Expressions of protein oxidation markers, dityrosine and advanced oxidation protein products in Cisplatin-induced nephrotoxicity in rats.
Topics: Animals; Antineoplastic Agents; Biomarkers; Cisplatin; Gene Expression Regulation; Kidney Diseases; Oxidation-Reduction; Rats; Time Factors; Tyrosine | 2011 |
Correlative studies of urine fluorescence and free radical indicators.
Topics: Cross-Sectional Studies; Feasibility Studies; Free Radicals; Glycation End Products, Advanced; Humans; Kidney Diseases; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index; Spectrometry, Fluorescence; Tyrosine | 2002 |